Small island developing states (SIDS) vs Tunisia: Proportion of the target population who received
Small island developing states (SIDS)
63.0%
in 2024
Tunisia
97.0%
in 2024
Small island developing states (SIDS) rank
16th
Tunisia rank
18th
Proportion of the target population who received over time
- Small island developing states (SIDS)
- Tunisia
How they compare
Tunisia currently reports 97.0% against 63.0% in Small island developing states (SIDS), a difference of 34.0%.
That makes Tunisia's figure about 1.5 times Small island developing states (SIDS)'s.
Across all 25 years both countries report, Tunisia has been ahead every year.
Small island developing states (SIDS) ranks 16th and Tunisia ranks 18th of 23 groups.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Small island developing states (SIDS) | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.6% | 98.4% | 78.8% | Tunisia |
| 2010s | 31.6% | 97.1% | 65.5% | Tunisia |
| 2020s | 56.8% | 97.2% | 40.4% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Small island developing states (SIDS) or Tunisia?
- Tunisia, at 97.0% against 63.0% in Small island developing states (SIDS) as of 2024.
- What is the difference in proportion of the target population who received between Small island developing states (SIDS) and Tunisia?
- 34.0%, with Tunisia ahead.
- How many years of comparable data are there for Small island developing states (SIDS) and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Small island developing states (SIDS) and Tunisia rank globally for proportion of the target population who received?
- Small island developing states (SIDS) ranks 16th and Tunisia ranks 18th of 23 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.